Objective: Coronavirus disease 2019 (COVID-19) is complexed infectious disease caused by severe respiratory syndrome (SARS) human coronavirus 2 (CoV-2). We have previously shown that the microRNA (miRNA) entangling sorter (METS) analysis with quantum miRNA/miRNA language is available for the etiology investigation in silico of human virus-associated diseases. To investigate COVID-19 etiology, SARS-CoV-2 infection was simulated by METS algorithm with artificial intelligence (AI) machine learning (MIRAI). Materials and Methods: The information of coronavirus was extracted from database. Putative CoV-2 miRNAs were predicted by functionally analogy analysis. Statistical data was calculated by Prediction One. Results: The quantum miRNA immunity was observed in SARS-CoV-2 infection. Acute inflammation and viral infection mechanisms in COVID-19 were independently shown in host and viral miRNA networks according to the output of MIRAI. SARS-CoV-2 infection induced IL-6 upregulation by downregulation of miR-98-5p hub, and hypoxia was induced protein HIF1A suppression by viral miRNAs. C1q complement inhibition was tuned by viral miRNAs. Conclusion:We found in silico that COVID-19 might show IL-6 production by host miRNAs, and hypoxic vascular hypertension and hypocomplementemia-like symptom by viral miRNAs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.